Most Recent
Bayer loses opposition to ‘Preceed’ weed killer trade mark
Intellectual Property 2020-04-20 12:43 pm By Christine Caulfield

Agricultural giant Bayer can’t block an Australian herbicide maker from trade marking ‘Preceed’ for its products, with a delegate from the Trade Marks Office finding […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Judge tosses Vagisil maker’s challenge to European rival’s trade mark
Intellectual Property 2020-02-04 11:43 am By Miklos Bolza

The international company behind the Vagisil feminine hygiene brand has lost its bid to stop a European competitor from registering Vagisan as a trade mark […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

160-year-old IP boutique Watermark to hang up its hat
Business of Law 2019-11-21 10:52 pm By Cat Fredenburgh

IP boutique Griffith Hack will soon have around 80 practicing lawyers when it absorbs Australia’s oldest specialist intellectual property firm Watermark next year. Intellectual property […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Kymab to attack Regeneron’s mice experiments in human rat patent case
Intellectual Property 2019-10-24 7:39 pm By Miklos Bolza

UK biopharmaceutical company Kymab may attack experiments done by US biotechnology giant Regeneron creating genetically modified mice with splices of human genomes, as it defends […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Delegate denies opposition to Kraft changes to heat-resistant chocolate patent
Intellectual Property 2019-10-23 4:35 pm By Cat Fredenburgh

Kraft Foods can amend its patent application for a chocolate that doesn’t melt in the summer months, after a delegate found many of the claims […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

BASF presses the brakes on Lubrizol fuel additive patent suit
Intellectual Property 2019-10-01 3:46 pm By Cat Fredenburgh

Chemical giant BASF has dropped a lawsuit against Lubrizol Corporation challenging proposed amendments to a fuel additive patent. The appeal, filed by BASF in March […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Juno, Millennium settle patent dispute over cancer drug Velcade
Intellectual Property 2019-09-30 11:56 am By Miklos Bolza

Generic drug maker Juno Pharmaceuticals and US-based Millennium Pharmaceuticals have reached an in-principle settlement in their trans-Pacific dispute over two patents covering breakthrough anti-cancer medication […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Regeneron steps up opposition to Kymab’s human rat patent
Intellectual Property 2019-08-26 12:47 pm By Cat Fredenburgh

US biotechnology company Regeneron Pharmaceuticals has filed a Federal Court challenge after losing its opposition to a patent application by UK biopharmaceutical company Kymab for […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Innovation patents phase out: What you need to know
Expert Insights 2019-08-07 9:54 pm By Editor

The Australian federal government’s proposed legislation to abolish the innovation patent system, Australia’s second tier patent system, was introduced into parliament on July 25. Here […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Regeneron loses opposition to Kymab’s patent for human rats
Intellectual Property 2019-08-01 2:30 pm By Miklos Bolza

US biotechnology firm Regeneron Pharmaceuticals has lost its opposition to a proposed patent by UK biopharmaceutical company Kymab for a method of producing an animal […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.